RiLuzole to Reduce Atrial FIb Study Using Holter Monitoring
NCT05292209
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
78
Enrollment
OTHER
Sponsor class
Conditions
Atrial Fibrillation Paroxysmal
Interventions
DRUG:
Riluzole 50 MG
Sponsor
University of Utah
Collaborators
[object Object]